Discover our partner StemBio, a groundbreaking biotechnology company in Turkey that’s revolutionizing medicine through stem cell and tissue technologies. As the first and only hybrid cell and tissue center in the country, StemBio operates across three key areas: CT blood banking, stem cell production and banking, and tissue banking.
Established in 2020 within the Tubac MK R&D and innovation region, their extensive facilities, including a 2,500 sq m closed area and an 800 sq m GMP laboratory, reflect their commitment to advanced technology and ethical practices. StemBio’s vision is to introduce global cellular and molecular health technologies to Turkey and lead the way in innovative advancements in the field.
Vitalia24 collaborates with StemBio to offer advanced stem cell treatments. These therapies aim to address neurological and developmental challenges, particularly in individuals with autism. The treatments involve stem cells and exosomes, which may help repair damaged neurons, modulate immune responses, and reduce inflammation in the brain. The goal is to improve cognitive function, behavior, and overall quality of life.
Are you interested in advanced stem cell treatments for autism or other neurological diseases?
Center Stembio was established in TÜBİTAK MARTEK R&D and Innovation region in 2020 with the aim of bringing new health technologies that have developed in the world at the cellular and molecular level to Turkey and to support the production of new information in this field.
Stembio, which uses stem cell processing methods, quality control tests and advanced cryopreservation techniques with its high-level expert staff and advanced technological infrastructure, provides services in various sub-sections.
1. Located within the TUBITAK Marmara Technopolis Campus;
2. 2400 m2 closed area
3. 800 m2 GMP Laboratory area
4. Class A Production Areas
5. Class B Cleanroom Preparation Areas Class D Quality Control and Storage Areas
6. BSL-3 Clean Room for High Risk Manufacturing Processes
The production department, which operates in cGMP B and A class sterile areas located in cGMP B and C class laboratories, has the ability to process both cell and tissue products in the same time period. This feature is available in very few centers in the world.
It is our department, which has the infrastructure and equipment to perform sterility, toxicity, pyrogenicity, genetic analysis, tumorigenicity analysis, flow-cytometry analysis, cellular analysis and environmental quality control processes. All necessary quality controls of all raw cells and tissues, consumables, and all cell and tissue products coming from the center are carried out in this department. The Department is able to keep under control 24/7 that the Center meets the cGMP environmental standards.
In our cryopreservation department, which has the capacity to bank 20,000 cellular products, 10,000 cord blood and 10,000 tissue products with our existing infrastructure, within GMP-controlled areas, there are liquid nitrogen tanks, -86°C deep freezers, and gradual freezing devices where cells and tissues can be frozen without losing their vitality.
It is our department where all raw cell and tissue materials and consumables coming to the center are taken to quarantine areas, samples are made and necessary controls are carried out and admitted to the center.
Welcome to our specialized medical practice, a dedicated team of professionals with extensive experience in stem cell and exosome therapies.